Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.565
-0.100 (-2.14%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Alterity Therapeutics Revenue

Alterity Therapeutics had revenue of 2.80M AUD in the half year ending December 31, 2025, with 47.49% growth. This brings the company's revenue in the last twelve months to 8.84M, up 137.32% year-over-year. In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 7.64M with 90.12% growth.

Revenue (ttm)
8.84M AUD
Revenue Growth
+137.32%
P/S Ratio
18.17
Revenue / Employee
982,113 AUD
Employees
9
Market Cap
80.43M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20257.64M3.62M90.12%
Jun 30, 20244.02M102.95K2.63%
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M638.30K14.23%
Jun 30, 20214.49M4.36M3,554.58%
Jun 30, 2020122.73K-4.83M-97.52%
Jun 30, 20194.95M1.83M58.40%
Jun 30, 20183.13M103.10K3.41%
Jun 30, 20173.02M-1.87M-38.27%
Jun 30, 20164.90M-1.60M-24.61%
Jun 30, 20156.49M-1.71M-20.89%
Jun 30, 20148.21M3.57M76.94%
Jun 30, 20134.64M2.11M83.56%
Jun 30, 20122.53M2.36M1,451.38%
Jun 30, 2011162.92K-52.09K-24.23%
Jun 30, 2010215.01K-213.19K-49.79%
Jun 30, 2009428.19K-62.92K-12.81%
Jun 30, 2008491.11K-16.32K-3.22%
Jun 30, 2007507.44K-542.85K-51.69%
Jun 30, 20061.05M-1.60M-60.41%
Jun 30, 20052.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics150.71M
Champions Oncology57.95M
NeurAxis4.28M
Rallybio858.00K
NeOnc Technologies Holdings39.99K
Revenue Rankings